Mekinist is an anti-cancer drug that interferes with the growth and spread of cancer cells in the body or cannot be surgically removed.
Mekinist can be used alone or in combination with another medicine called dabrafenib (Tafinlar) to
treat certain types of people with mutations in the "BRAF" gene have cancer. It should only be used in people with specific changes (mutations) in a gene called "BRAF" in cancer. Before starting treatment with MEKINIST, a cancer check should be performed for this change in the BRAF gene.
Mekinist is used to treat:
Melanoma (skin cancer) that cannot be treated by surgery or has spread to other parts of the body, or prevents melanoma from recurring after surgery;
Non-small cell lung cancer that has spread to other parts of the body; or
There is no other treatment option for advanced or metastatic thyroid cancer that has spread.
Important information
Using Mekinist with dabrafenib may increase the risk of developing some types of skin cancer. Ask your doctor about your specific risks. If you find any new skin symptoms, please tell your doctor.
Follow all instructions on the drug label and packaging. Tell each of your health care providers about your medical condition, Allergies, and all medications you use.
Before taking this medicine
If you are allergic to trametinib, you should not use Mekinist.
To ensure that Mekinist is safe for you, please tell your doctor if you have:
Supplied/Storage and Handling
MEKINIST tablets are administered orally in the form of 0.5 mg, 1 mg and 2 mg tablets. 0.5 mg
Tablet: yellow, Improved oval, biconvex, film-coated tablets, with "GS" on one side and "TFC" on the opposite side, 30 bottles per bottle (NDC 0173-0849-13). 1-mg tablets: white, Round, biconvex, film-coated tablets with "GS" engraved on one side and "LHE" on the opposite side, can be bottled 30 (NDC 0173-0858-13). 2-mg tablets: pink, round, biconvex, film-coated tablets with "GS" engraved on one side and "HMJ" on the opposite side Face pack, 30 bottles per bottle (NDC 0173-084813)
Store refrigerated at 2 ° to 8 ° C (36 ° to 46 ° F). Don't freeze. Dispense the original bottle.
Do not remove desiccant. Moisture-proof And light. Do not put the medicine in the pill box.
If you want to know more about MEKINIST Click Here
Mekinist can be used alone or in combination with another medicine called dabrafenib (Tafinlar) to
treat certain types of people with mutations in the "BRAF" gene have cancer. It should only be used in people with specific changes (mutations) in a gene called "BRAF" in cancer. Before starting treatment with MEKINIST, a cancer check should be performed for this change in the BRAF gene.
Mekinist is used to treat:
Melanoma (skin cancer) that cannot be treated by surgery or has spread to other parts of the body, or prevents melanoma from recurring after surgery;
Non-small cell lung cancer that has spread to other parts of the body; or
There is no other treatment option for advanced or metastatic thyroid cancer that has spread.
Important information
Using Mekinist with dabrafenib may increase the risk of developing some types of skin cancer. Ask your doctor about your specific risks. If you find any new skin symptoms, please tell your doctor.
Follow all instructions on the drug label and packaging. Tell each of your health care providers about your medical condition, Allergies, and all medications you use.
Before taking this medicine
If you are allergic to trametinib, you should not use Mekinist.
To ensure that Mekinist is safe for you, please tell your doctor if you have:
- Heart disease, high blood pressure;
- Diabetes;
- Lung disease;
- Liver or kidney disease;
- Stomach or intestinal diseases;
- Eye problems (especially retinal problems); or
- Bleeding problems or blood clots.
Supplied/Storage and Handling
MEKINIST tablets are administered orally in the form of 0.5 mg, 1 mg and 2 mg tablets. 0.5 mg
Tablet: yellow, Improved oval, biconvex, film-coated tablets, with "GS" on one side and "TFC" on the opposite side, 30 bottles per bottle (NDC 0173-0849-13). 1-mg tablets: white, Round, biconvex, film-coated tablets with "GS" engraved on one side and "LHE" on the opposite side, can be bottled 30 (NDC 0173-0858-13). 2-mg tablets: pink, round, biconvex, film-coated tablets with "GS" engraved on one side and "HMJ" on the opposite side Face pack, 30 bottles per bottle (NDC 0173-084813)
Store refrigerated at 2 ° to 8 ° C (36 ° to 46 ° F). Don't freeze. Dispense the original bottle.
Do not remove desiccant. Moisture-proof And light. Do not put the medicine in the pill box.
If you want to know more about MEKINIST Click Here
No comments:
Post a Comment